These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 887938)

  • 1. Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids.
    Hammarström S; Hamberg M; Duell EA; Stawiski MA; Anderson TF; Voorhees JJ
    Science; 1977 Sep; 197(4307):994-6. PubMed ID: 887938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of glucocorticoid on arachidonic acid content of lesions of psoriasis.
    Voorhees JJ; Duell EA; Anderson TF; Stawiski MA; Hammarström S; Hamberg M
    Adv Prostaglandin Thromboxane Res; 1978; 3():175-81. PubMed ID: 350021
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
    Ruzicka T
    Hautarzt; 1985 May; 36(5):255-8. PubMed ID: 2989218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 6. Arachidonic acid transformations in normal and psoriatic skin.
    Hammarström S; Lindgren JA; Marcelo C; Duell EA; Anderson TF; Voorhees JJ
    J Invest Dermatol; 1979 Aug; 73(2):180-3. PubMed ID: 572390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psoriasis and non steroidal anti-inflammatory agents].
    Ferrier MC; Souteyrand P
    Ann Dermatol Venereol; 1992; 119(8):591-5. PubMed ID: 1485768
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
    Voorhees JJ
    Arch Dermatol; 1983 Jul; 119(7):541-7. PubMed ID: 6305285
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
    Arbiser JL; Grossman K; Kaye E; Arndt KA
    Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
    van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
    Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
    Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
    Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites of arachidonic acid in psoriasis.
    Wilkinson DI
    Cutis; 1984 Apr; 33(4):353, 358. PubMed ID: 6426865
    [No Abstract]   [Full Text] [Related]  

  • 13. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.
    Hammarström S; Hamberg M; Samuelsson B; Duell EA; Stawiski M; Voorhees JJ
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5130-4. PubMed ID: 1061097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
    Leibsohn E
    J Int Med Res; 1982; 10(1):22-7. PubMed ID: 7073809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation.
    Kragballe K; Voorhees JJ
    Acta Derm Venereol Suppl (Stockh); 1985; 120():12-7. PubMed ID: 3010612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transepidermal elimination following the use of a topical adrenal steroid.
    Katz R; Hood AF
    Arch Dermatol; 1985 Mar; 121(3):412-3. PubMed ID: 3977366
    [No Abstract]   [Full Text] [Related]  

  • 18. Percutaneous absorption of betamethasone-17, 21-dipropionate and salicylic acid during the treatment of psoriasis and eczema.
    Gip L; Hamfelt A
    J Int Med Res; 1976; 4(2):106-10. PubMed ID: 799983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 derivatives, alone or in combination with glucocorticoids, suppress streptococcal pyrogenic enterotoxin A-stimulated proliferation of peripheral blood mononuclear cells in patients with psoriasis.
    Usui K; Okubo Y; Hirano T; Tsuboi R
    J Dermatol; 2017 May; 44(5):567-572. PubMed ID: 28012189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.